Functional roles of exosomal miRNAs in multi-drug resistance in cancer chemotherapeutics

被引:9
作者
Mowla, Mahshid [1 ]
Hashemi, Atieh [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
关键词
Multidrug resistance; Exosome; microRNA; exomiR; Chemotherapy;
D O I
10.1016/j.yexmp.2020.104592
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent understanding of different molecular aspects of tumor initiation and progression has led to the discovery of a growing list of drugs. While these drugs have shown promising effects on tumor cells, their widespread usage has been hampered by the acquisition of drug resistance in a subpopulation of tumor cells. A differential pattern in the secretion of specialized vesicles named "exosomes" in drug-resistant cancer cells have recently received much attention. In addition, microRNAs (miRNAs) have been shown to be enriched in exosomes. Exosomal miRNAs (also known as exo-miRs) could be shuttled to recipient cells and play a role in the regulation of post-transcriptional gene expression, which may exert certain effects on cancer drug resistance. Here, we have reviewed the role of exo-miRs in chemotherapeutic resistance in different cancer types. Besides, studies which have focused on predictive role of circulating exo-miRs in cancer drug resistance are reviewed.
引用
收藏
页数:11
相关论文
共 134 条
[111]   MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer [J].
Xie, Manxin ;
Fu, Ziyi ;
Cao, Jianxiang ;
Liu, Yuan ;
Wu, Jie ;
Li, Qing ;
Chen, Yun .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 :286-294
[112]   Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1 [J].
Xie, Zheng-Yuan ;
Wang, Fen-Fen ;
Xiao, Zhi-Hua ;
Liu, Si-Fu ;
Tang, Sheng-Lan ;
Lai, Yue-Liang .
JOURNAL OF BIOCHEMISTRY, 2020, 167 (06) :557-564
[113]   Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma [J].
Yang, Jian-Kai ;
Yang, Ji-Peng ;
Tong, Jing ;
Jing, Shi-Yuan ;
Fan, Bo ;
Wang, Feng ;
Sun, Guo-Zhu ;
Jiao, Bao-Hua .
JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (02) :255-265
[114]  
Yang YC, 2019, EUR REV MED PHARMACO, V23, P1513, DOI 10.26355/eurrev_201902_17109
[115]   MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling [J].
Yin, Yingchun ;
Wang, Xinmei ;
Li, Tangyue ;
Ren, Qi ;
Li, Liang ;
Sun, Xiaoyu ;
Zhang, Baohua ;
Wang, Xinyun ;
Han, Hongmei ;
He, Yangyang ;
Cao, Zhen ;
Sun, Xiaojie ;
Zhou, Ziqiang .
CANCER MEDICINE, 2020, 9 (04) :1544-1552
[116]  
Yu J.X., 2017, MICRORNA 125B REVERS, P2223
[117]  
Zeppa, 2010, REV ARTICLE TREATMEN, DOI [10.3978/j.issn.2072-1439.2010.12.08, DOI 10.3978/J.ISSN.2072-1439.2010.12.08]
[118]   Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL [J].
Zhan, Min ;
Qu, Qiang ;
Wang, Guo ;
Zhou, Honghao .
PHARMAZIE, 2013, 68 (12) :955-961
[119]  
Zhang, 2018, UP REGULATION MIR 21, P1, DOI [10.1096/fj.201801013R., DOI 10.1096/FJ.201801013R]
[120]  
Zhang, 2016, MIRNA 205 TARGETS VE, DOI [10.1038/cddis.2016.194., DOI 10.1038/CDDIS.2016.194]